Comparing in-person and virtual group therapy to prevent postpartum depression
Group-based Prevention of Postpartum Depression: In-person vs. Virtual Delivery
This study is testing whether a group therapy program delivered online or in-person can help prevent postpartum depression in pregnant women, especially those from disadvantaged backgrounds.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 900 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University of Denver Academic / other |
| Locations | 1 site (Denver, Colorado) |
| Trial ID | NCT05766475 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of a group interpersonal therapy program, known as ROSE, in preventing postpartum depression (PPD) when delivered virtually versus in-person. The study focuses on pregnant women, particularly from socioeconomically disadvantaged and minoritized backgrounds, to address significant health disparities. Participants will be randomly assigned to receive the ROSE program either in-person at their prenatal care hospital or virtually through video conferencing, with sessions available in both English and Spanish. The trial will involve 900 diverse pregnant individuals to assess the scalability and accessibility of the intervention.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women who are less than 30 weeks gestational age and speak either English or Spanish.
Not a fit: Patients who are not pregnant or those who are beyond 30 weeks gestational age will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a scalable and accessible method for preventing postpartum depression among diverse populations.
How similar studies have performed: Other studies have shown success with similar virtual interventions for mental health, indicating potential for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * English or Spanish speaking * Less than 30 gestational weeks Exclusion Criteria: * None
Where this trial is running
Denver, Colorado
- Denver Health Medical Center — Denver, Colorado, United States (Recruiting)
Study contacts
- Principal investigator: Galena Rhoades, PhD — University of Denver
- Study coordinator: Galena Rhoades, PhD
- Email: Galena.Rhoades@du.edu
- Phone: 303-871-4280
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.